Covid-19 manufacturing report: Ireland will produce mRNA component for Pfizer's vaccine; Lonza recruits federal employees for rapid ramp-up
An existing Pfizer plant in Dublin will produce a component of the company’s mRNA vaccine, the company announced Wednesday. Output will start by the end of this year.
Ireland’s Prime Minister Micheál Martin referenced the news in a tweet Wednesday.
“Great news that (Pfizer) will soon begin production of #CovidVaccines here in Ireland,” he said. “Not only will the $40m investment create 75 new jobs at Grange Castle in Dublin – it also puts Ireland at the heart of the EU’s fight against the pandemic.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.